PATENT CLAIM ANALYSIS

Application Number: 16036381
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-03
Patent Classification: ["424", "190100"]

Abstract:
Methods and apparatus are provided for applying an fragment of a neurotoxin such as the active light chain (LC) of the botulinum toxin (BoNT), such as one of the serotype A, B, C, D, E, F or G botulinum toxins, via permeabilization of targeted cell membranes to enable translocation of the botulinum neurotoxin light chain (BoNT-LC) molecule across the targeted cell membrane to the cell cytosol where a therapeutic response is produced in a mammalian system. The methods and apparatus include use of catheter based delivery systems, non-invasive delivery systems, and transdermal delivery systems.

Claim (Index 28):
The device of  claim 28 , wherein the expandable member is further configured to expand such that the expandable member engages a second portion of the airway wall.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 95.0
- Lexical Diversity: 1.63235
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14601529', '13660629', '13253595', '12559278', '11459090']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7722396782540213
- 35 USC 102 Novelty (BERT): 0.5729379441298654
- Combined Prediction Score: 0.7523095048416057
- Mean Citation Score: 396.601012
- Max Citation Score: 485.664
- Similarity Product: 351.0100704059601

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test